3rd Quarter - Report

HEALTHCARE INSTITUTE OF NEW JERSEY for HEALTHCARE INSTITUTE OF NEW JERSEY

Firm
Client
Income
—
Expenses
$80,000
Expense method
C: businesses, Internal Revenue Code section 162(e)

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Torts TOR

Oppose the Medical Device Safety Act of 2008

LobbyistCovered position, as disclosed
ROBERT D FRANKS —
STEVE ISSENMAN —
SARAH G KAN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Copyright/Patent/Trademark CPT

Amending the Patent Reform Act of 2008 in the Senate

LobbyistCovered position, as disclosed
STEVE ISSENMAN —
SARAH G KAN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Trade (domestic/foreign) TRD

Advocating for patent protections in trade bills and in foreign government operations

LobbyistCovered position, as disclosed
STEVE ISSENMAN —
SARAH G KAN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Health Issues HCR

Promoting understanding of the causes and cost of chronic disease.

LobbyistCovered position, as disclosed
ROBERT D FRANKS Members of Congress 1992-2000
STEVE ISSENMAN —
SARAH G KAN Congressional Aide 1999-2002

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Medicare/Medicaid MMM

Advocating on behalf of Medicare Part D open access and encouraging open market access to medications

LobbyistCovered position, as disclosed
ROBERT D FRANKS —
STEVE ISSENMAN —
SARAH G KAN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.